Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "kidney"

241 News Found

Yashoda Hospitals, Hyderabad saves five-year-old with timely kidney surgery
Hospitals | December 08, 2021

Yashoda Hospitals, Hyderabad saves five-year-old with timely kidney surgery

Approximately five kg tumor was removed in the eight-hour long complicated surgery


Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
Biotech | November 23, 2021

Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease

The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis


Japan approves AstraZeneca’s Forxiga for chronic kidney disease
Drug Approval | August 28, 2021

Japan approves AstraZeneca’s Forxiga for chronic kidney disease

Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options


Pune-based Jehangir Hospital records 500 kidney transplants
Healthcare | August 25, 2021

Pune-based Jehangir Hospital records 500 kidney transplants

The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant


Apollo Hospitals holds organ donation awareness
Hospitals | June 08, 2026

Apollo Hospitals holds organ donation awareness

Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation


AstraZeneca reports mixed Phase III results for anselamimab in rare cardiac amyloidosis trial
Clinical Trials | May 30, 2026

AstraZeneca reports mixed Phase III results for anselamimab in rare cardiac amyloidosis trial

The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis


Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
R&D | May 28, 2026

Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026

The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs


Novo Nordisk study exposes “hidden” inflammation driving cardio risk despite care
News | May 27, 2026

Novo Nordisk study exposes “hidden” inflammation driving cardio risk despite care

POSEIDON is among the largest global datasets to quantify this residual inflammatory burden


Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization